News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EMD Chemicals, Inc. (MRK) Launches First Bead-Based Multiplex Assays Using EpiTag™ Technology from Epitome Biosystems


2/11/2008 9:18:46 AM

GIBBSTOWN, N.J. & WALTHAM, Mass.--(BUSINESS WIRE)--EMD Chemicals, Inc. (EMD), a subsidiary of Merck KGaA, Darmstadt, Germany, and Epitome Biosystems, Inc, announced today that EMD has launched WideScreen™ EpiTag™ ERK Pathway Assays, the first wave of bead-based, multiplex assays using EpiTag™ Technology licensed from Epitome Biosystems. The new line of assays will enable researchers to make quantitative, highly multiplexed measurements of important cell targets, greatly facilitating drug discovery efforts.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES